USPTO serial 79383235
LIAISON NES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 8, 2024
- Examiner
- GREEN, ASHLEY ELIZABETH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LIAISON NES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter HAUG PARTNERS, LLP745 FIFTH AVNUENEW YORK, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in science; Chemical diagnostic reagents for scientific purposes; Diagnostic preparations, other than for medical or veterinary purposes; Reagent bearing diagnostic strips for testing of infectious diseases and organic molecules, other than for medical or veterinary use; Diagnostic testing materials, other than for medical use in the nature of reagent bearing diagnostic strips for testing saliva; Control preparations, namely, chemical control solutions for in vitro diagnostic testing, screening, confirmation and analysis for laboratory or research use; Diagnostic reagents and chemical reagents for scientific or research purposes; Solutions in the nature of chemical control solutions used in diagnostic test kits for laboratory or research purposes; Chemically treated non-medical test strips for laboratory or research purposes; Diagnostic preparations for laboratory or research use; Diagnostic preparations for use in assessment of toxicological property of chemical compounds and mixture for scientific use; Diagnostic biomarkers for analytical, research and scientific use; Diagnostic preparations for in vitro testing for scientific use; nucleic acids; nucleic acids for scientific purposes | ACTIVE | — |
| 005 | Medical diagnostic test reagents for testing body fluids for veterinary use; Medical diagnostic test reagents for testing body fluids for medical purposes; Diagnostic agents for medical use; Chemical reagents for medical or veterinary purposes; Diagnostic kits comprising medical diagnostic bioagents for extracting, testing and analyzing body fluids; Diagnostic test kits comprising medical diagnostic reagents and assays for testing of body fluids for use in disease detection, namely, infectious disease, and detection of biological parameters; Diagnostic testing materials for medical use, namely, medical diagnostic test strips for use in the field of infectious diseases and detection of biological parameters; Medical diagnostic test strips for blood analysis; Virus testing preparations for medical use; Medical diagnostic assays for medical use; In vitro medical diagnostic tests for use in disease testing; In vitro medical diagnostic assays for use in disease testing; In vitro medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; In vitro medical diagnostic test strips for blood analysis; In vitro medical diagnostic reagents; Medical diagnostic test strips for the detection, diagnosis, screening and confirmation of viruses and infections; Reagents and test strips for medical purposes for use as indicators of disease and such indicators being antigens and antibodies; Immunoassay reagents for medical use; Biological and chemical preparations and reagents for medical or veterinary purposes for the detection of infectious diseases; Biochemical preparations for medical or veterinary purposes for the detection of infectious diseases; Bacterial preparations for medical and veterinary use; Nucleic acid sequences for medical and veterinary purposes; Medical diagnostic regents for the detection of pathogens responsible for respiratory infections in the nature of influenza, COVID-19 and Group A streptococcus; Medical diagnostic reagents for the detection of pathogens responsible for sexually transmitted infections | ACTIVE | — |
| 009 | Downloadable computer software mobile applications for use in diagnosing individuals; Downloadable computer software for medical diagnostics and for operating diagnostic apparatus that is not for medical purposes; Testing machines and instruments for diagnostic purposes, other than for medical use, namely apparatuses composed of PC tablets and optical readers for testing liquids and solids; Downloadable portable and cloud-connected point of care (POC) immunodiagnostic software platforms for diagnosing individuals; Downloadable computer software and hardware for the design, creation and control of tools for medical diagnostics; Downloadable software for processing data; Apparatus, equipment, hardware and computers for diagnostics; Data storage, processing and transmission apparatus for diagnostic purposes, namely, blank tapes for storing computer data; Data processing equipment, namely, optical readers for diagnostic purposes; PC tablets used for test and diagnostic purposes; Video monitors; Testing apparatus not for medical purposes, namely, apparatus for testing liquids and solids; Measuring or testing machines and instruments for diagnostic purpose, other than for medical use, namely, apparatus composed of PC tablets and optical readers for testing liquids and solids; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids | ACTIVE | — |
| 010 | Diagnostic testing apparatus for medical purposes for testing biomarkers and biomolecules; Medical diagnostic apparatus for medical purposes; Tools for medical diagnostics, namely, medical diagnostic apparatus for testing for viruses and infectious disease; Medical devices for diagnosing viruses; Medical testing equipment, namely, medical device for detecting antibodies against SARS-CoV-2; Medical apparatus for medical analysis of bacteria; Electronic analyzers for bacterial identification for medical purposes; Apparatus for taking blood samples; Apparatus for taking body fluid samples; Point of care (POC) diagnostic, examination and monitoring equipment, namely, respiratory equipment and monitors therefor; Point of care (POC) immunochemical testing apparatus for carrying out diagnostic tests for medical purposes; Diagnostic apparatus for the identification of specific antibodies against SARS-CoV-2 in capillary blood samples; Diagnostic apparatus for the identification of virus, bacterial infections and infectious diseases; Radiological diagnostic imaging apparatus for medical purposes in the field of immunochemistry; Medical diagnostic apparatus for testing for viruses; Apparatus for DNA and RNA testing for medical purposes; Syringes for injections; Extraction medical syringes; Disposable hypodermic syringes for medical use; Medical syringe needles; Medical diagnostic apparatus for the identification of respiratory infections in the nature of influenza, SARS-CoV-2 and Group A streptococcus; Medical diagnostic apparatus for the identification of sexually transmitted infections; Molecular platform designed for the detection of pathogens causing infectious diseases through PCR nucleic acid amplification technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named LIAISON NES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 3, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 15, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 15, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 4, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 19, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 19, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 8, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 8, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 8, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 15, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 9, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 9, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 14, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 13, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |